Search

everythinglearnresearchcommunity

for

Search:↓

Continued ritlecitinib treatment can lead to hair regrowth in some patients with alopecia areata who initially don't respond.

A new mutation in the LIPH gene was found to cause a rare hair disorder in a Japanese boy.

BMAL1 controls skin cell growth and UV damage risk, peaking at night.

BMP signaling controls hair growth and skin color.

PrrH sRNA controls pyochelin production in *Pseudomonas aeruginosa*.

KLHL24-mutant stem cells help understand skin and heart disease.

Different prostate cancer treatments have similar risks of secondary cancers and related mortality when considering patient age and smoking history.

Rhupus is a complex syndrome that combines rheumatoid arthritis and lupus, making diagnosis challenging.

PRP can improve skin beauty naturally but doesn't last as long as plastic surgery.

TIP39 and PTH2R help control calcium levels and skin cell development.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.

The new synthetic retinoid RO 13-6298 effectively treated severe psoriasis at low doses with manageable side effects.

Combining platelet-rich plasma injections and gel may effectively treat morphea, improving skin elasticity and reducing pain.

Bardet-Biedl syndrome may include under-recognized skin problems related to its metabolic disturbances.

PRIDE syndrome helps identify skin side effects from EGFR inhibitors like erlotinib.

Ipilimumab can cause various adverse events in elderly patients, especially affecting the gastrointestinal and endocrine systems.

Abrocitinib at 100 mg and 200 mg daily may significantly improve moderate-to-severe atopic dermatitis in patients 12 years and older.

HPH-15, a new compound, effectively reduces skin fibrosis in experiments without causing harm.

Platelet-rich plasma shows promise in reducing pain for bladder pain syndrome.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

Ripretinib is effective and safe for treating advanced GIST in Chinese patients, particularly for non-gastric GISTs.

Early diagnosis of pseudopelade of Brocq in men is crucial to prevent permanent hair loss.

LPA 4 helps control blood and lymph vessel development in zebrafish.

Platelet-rich plasma can temporarily inhibit some drug-resistant bacteria in diabetic foot infections.

Naive Bayes algorithm can help predict hair loss risk early.

Dermatologists should guide patients on blood donation timing due to various eligibility criteria.

Proper niche formation in Drosophila requires Slit-Robo signaling for cell migration.

Ruxolitinib helped a woman with a genetic mutation regrow her hair and improved her health.